Hospital
ST. Lukes Episcopal-Presbyterian Hospital
ST. Lukes Episcopal-Presbyterian Hospital was paid $3.55M by Medicaid between Jan 2018 and Dec 2024, across 26 billing codes. Its largest line is 99283, emergency room visit (moderate) — 93% of everything it billed.
33Billing provider infoST. LUKES EPISCOPAL-PRESBYTERIAN HOSPITAL
CHESTERFIELD, MO 63017
CHESTERFIELD, MO 63017
33aNPI1346251543assigned 08/11/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.55M
24GClaims35,752
24DCodes billed26
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Missouri
Rank by total paid#40 of 74
Median peer was paid$4.44M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,516 | $56K | |
| 2019 | 1,187 | $22K | |
| 2020 | 537 | $26K | |
| 2021 | 4,612 | $59K | |
| 2022 | 10,291 | $865K | |
| 2023 | 10,732 | $1.41M | |
| 2024incomplete | 6,877 | $1.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 93% | 25,408 | 24,889 | $3.31M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.5% | 2,084 | 2,050 | $53K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 1,939 | 1,889 | $43K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 629 | 623 | $37K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,482 | 2,436 | $26K |
| X4003 | <1% | 375 | 355 | $21K | |
| Y7506 | <1% | 474 | 383 | $21K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 206 | 206 | $15K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 140 | 138 | $12K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | <1% | 27 | 24 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 15 | 12 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 106 | 98 | $448.59 |
14 more codes
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 26 | $300.00 |
| 80053 | Comprehensive metabolic panel | <1% | 27 | $204.90 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 237 | $0.00 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 218 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 182 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 168 | $0.00 |
| 99152 | 0% | 96 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 12 | $0.00 |
| J3490 | Unclassified drugs | 0% | 342 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 95 | $0.00 |
| C1769 | Guide wire | 0% | 235 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 42 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 93 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 94 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBAGNALL, ANDREW (PRESIDENT AND CEO)
| Provider | Location | Paid |
|---|---|---|
| Sacred Heart Hospital of the Hospital Sisters of the 3RD Order of ST F | Eau Claire, WI | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.